Press release
New Research Report on Hormonal Contraception, 2016-2026
Hormonal contraception is type of pregnancy prevention techniques which act on the endocrine system. In this method various female hormones are used to prevent ovulation. Two forms of hormonal contraceptive formulations are available in combination forms such as estrogen and a progestin. However, progestogen is the only method which contains progesterone or any one of its synthetic analogues. In combination method the therapeutic effect is achieved by suppressing ovulation and thickening of cervical mucus, whereas progestogen only method decrease the frequency of ovulation.Various types of hormonal contraception methods are now available in the market which includes oral pill, skin patch, intrauterine device (IUD), injection, and implantation of rod that is worn underneath the skin. Depending upon type of hormonal contraception it is determined whether the hormonal exposure is continuous or intermittent. All approaches of hormonal contraception are based on prevention of implanting a fertilized egg in female’s womb (uterus) and start to develop or preventing sperm and egg from fertilization. New and improved methods of hormonal contraception are being developed as the efficacy of several methods may differ under various circumstances.
Hormonal Contraception Market: Drivers and Restraints
Global hormonal contraception are widely used globally by females. Adoption of hormonal contraception for birth control is increased due the community awareness in making precise decisions relating to reproductively and sexual health. The growth of hormonal contraception market is fuelled by rise in female population globally, urbanization and increased consciousness about hormonal contraception and also encouraging NGO and government policies to promote hormonal contraception. Implementation of temporary and low cost contraceptive practices instead of permanent contraception is the vital factor driving global market for hormonal contraception market. The adverse side effects linked with use of hormonal contraceptives acts as major barrier for global market during the forecast period.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1402
Hormonal Contraception Market: Segmentation
The hormonal contraceptionmarket is classified on the basis of product type and end user
By Product Type:
Oral Pill
Skin Patch
Intrauterine Device (IUD)
Injection
Implantation
By End Use:
Hospitals
Homecare Settings
Gynecology Centers
Clinics
Ambulatory Surgical Centers
Hormonal Contraception: Market Overview
Increasing support by the government in populated countries, rising awareness towards personal healthcare and monitoring, and wide acceptance of hormonal contraception among females around the globe are the factors driving the growth of hormonal contraception market. The fact that pregnancy can be resumed after terminating the use of hormonal contraception plays key role for growth of the global hormonal contraception market. The global hormonal contraception market is expected to grow at a remarkable CAGR in the forecast period (2016-2026).
Hormonal Contraception Market: Region-wise Outlook
Depending on geographic region hormonal contraception global market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan and Middle East & Africa.Hormonal contraceptives are dominating in North America due to their ease of use. Europe and Asia pacific regions are likely to grow at a significant CAGR for hormonal contraception market. Countries like China and India are promising to contribute to the hormonal contraception market due to vast population pool.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1402
Hormonal Contraception Market: Key Players
Some of the key players identified in the global hormonal contraception market are Bayer Pharma AG, Merck & Co., Inc., Afaxys, Inc. Charleston, SC., Agile Therapeutics Inc, Teva Pharmaceutical Industries Limited, and others.
ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.
CONTACT:
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New Research Report on Hormonal Contraception, 2016-2026 here
News-ID: 359685 • Views: …
More Releases from Future Market Insights

Workstation Software Market to Soar to USD 43.9 Billion by 2035, Fueled by 3D Mo …
Rising Demand for Workstation Software Across Industries
The global workstation software market is set for robust growth, driven by increasing demand for advanced visualization, simulation, and design tools across industries such as manufacturing, architecture, media, and entertainment. Valued at USD 14.8 billion in 2025, the market is projected to reach USD 43.9 billion by 2035, registering a compound annual growth rate (CAGR) of 11.5%. This surge reflects the rising complexity of…

Bean Flour Market Set for Robust Growth in the USA at 6.27% CAGR Through 2035
The global bean flour market is entering a period of remarkable expansion, driven by surging demand for plant-based nutrition and gluten-free alternatives. Analysts forecast the market to grow from USD 5,075.3 million in 2025 to USD 9,262.0 million by 2035, reflecting a CAGR of 6.2%. This trajectory highlights an unparalleled opportunity for manufacturers to address evolving consumer preferences while enhancing sustainability and profitability.
As the world shifts towards cleaner diets and…

Blueberry Ingredient Market Set to Soar with 6.27% Growth in the USA by 2035
The blueberry ingredient industry has firmly established itself as a cornerstone of the functional foods, nutraceuticals, and natural flavoring sectors. Analysts project the market valuation to reach approximately USD 2.8 billion by 2025, with a robust CAGR of 6.5% forecasted from 2025 to 2035. This growth is being fueled by the escalating demand for clean-label products, plant-based formulations, and functional solutions across the food, beverage, and cosmetic industries.
Click Here for…

Activated Cake Emulsifier Market Set for 6.27% Growth in the USA, Poised to Tran …
The activated cake emulsifier market is entering a transformative phase, driven by evolving consumer preferences toward premium, high-quality bakery products. Estimated to reach USD 1,343.2 million in 2025, the market is projected to achieve USD 2,360.5 million by 2035, representing a robust 5.8% CAGR over the next decade. This growth offers a strategic opportunity for manufacturers to meet rising consumer demands while future-proofing operations through innovation, regional customization, and sustainability.
Click…
More Releases for Hormonal
United States Endometriosis Treatment Market Report 2025: Pain Medication, Hormo …
The Global Endometriosis Treatment market reached US$ 1.59 billion in 2024 and is expected to reach US$ 3.91 billion by 2033, growing at a CAGR of 10.62% during the forecast period 2025-2033.
The Endometriosis Treatment Market encompasses the range of pharmaceutical drugs, hormonal therapies, surgical interventions, and diagnostic tools used to manage and treat endometriosis a chronic condition where tissue similar to the endometrium grows outside the uterus, causing pain, infertility,…
Contraceptives Market Detailed in New Research Report with Emerging Hormonal and …
Contraceptives Market Insights
Global contraceptive market was valued US$ 19.79 Bn in 2025 and is expected to reach US$ 47.14 Bn by 2032 exhibiting a compound annual growth rate (CAGR) of 13.20% from 2025 to 2032.
Coherent Market Insights has released a detailed analysis of the Contraceptives Market (2025-2032), focusing on the evolving U.S. healthcare landscape. The report presents critical metrics such as market size, revenue forecasts, CAGR, adoption patterns, and key…
Hormonal Contraceptives Market - Confidence, Convenience, and Control: Elevating …
Newark, New Castle, USA: The "Hormonal Contraceptives Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Hormonal Contraceptives Market: https://www.growthplusreports.com/report/hormonal-contraceptives-market/7790
This latest report researches the industry structure, sales, revenue,…
Non-Hormonal Birth Control Market - Empowering Choice, Embracing Control: Non-Ho …
Newark, New Castle, USA - new report, titled Non-Hormonal Birth Control Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Non-Hormonal Birth Control market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Non-Hormonal Birth Control market. The report offers an overview of…
Hormonal Contraceptives Market Size, Share | Hormonal Contraceptives Industry Fu …
Global Hormonal Contraceptives Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Hormonal Contraceptives Market research report provides a point-by-pointIn-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations,…
High Awareness in Female Population Regarding Hormonal Disorders Drives the Pres …
Global Prescription Hormonal Drugs Market in Gynecology: Description
Hormonal imbalance in women is caused due to abnormalities in the secretion of estrogen, progesterone and as well as androgens. A wide array of symptoms might be experienced by patients depending on the type of abnormality such as hot flushes, depression, vaginal dryness, excessive hair growth and abnormal vaginal bleeding. Environmental and genetic factors have an influence on women's fertility through their effect…